Stockhub

Arovella Therapeutics Limited: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

18 August 2022

  • curprev 02:5902:59, 18 August 2022 >Paris 1,128 bytes +1,128 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Arovella Therapeutics Limited, a biotechnology company, focuses on the development of therapies for the treatment of cancer and conditions that affect the central nervous system in Australia and internationally. The company's product pipeline includes ZolpiMist, an oral spray of zolpidem tartrate to treat short-term insomnia, which is marketed under the brand name of Ambien or Stilnox; Sumatriptan, an oral spray formulation..."
Retrieved from "https://stockhub.co/research/Arovella_Therapeutics_Limited"